| Deler fremragende | 60,303,212 shares |
| Insideraktier | 4.229.212 shares |
| Insider ejerskab | 7,01 % |
| Total Insiders | 22 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Damora Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Julianne Bruno Director - [D] | 137.032 | 137.032 | |
| Stephan Christgau Director - [D] | 546.136 | 21.845 | |
| Jayson Donald Alexander Dallas | 0 | ||
|
Fairmount Funds Management LLC
Director, 10% Owner -
[D]
|
2.904.000 | 2.904.000 | |
| Lori Firmani Chief Financial Officer - [O] | 931 | 931 | |
| Jonathan Freve Chief Financial Officer - [O] | 12.000 | 480 | |
| Carl Goldfischer Director - [D] | 19.432 | 777 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Hewes L. Becker Chief Medical Officer - [O] | 264.629 | 264.629 | |
| Jennifer Jarrett See Remarks, Director - [D] [O] | 500.000 | 500.000 | |
|
Chau Quang Khuong
Director, 10% Owner -
[D]
|
1.031.811 | 41.272 | |
| Bertil Lindmark Chief Medical Officer - [O] | 16.604 | 664 | |
| Soren Moller | 0 | ||
| Amit Munshi Director - [D] | 4.793 | 192 | |
|
A/S Novo
10% Owner -
|
2.497.791 | 99.912 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Orbimed Advisors Llc
10% Owner -
|
1.510.375 | 60.415 | |
| Stephanie Oestreich | 140.000 | ||
|
OrbiMed Genesis GP LLC
Director, 10% Owner -
[D]
|
1.031.811 | 60.415 | |
| Anders Pedersen Chief Operating Officer - [O] | 3.746 | 150 | |
| Anne Prener | 0 | ||
| Sherwin Sattarzadeh Chief Operating Officer - [O] | 190.376 | 190.376 | |
| Schambye Hans T. Chief Executive Officer, Director - [D] [O] | 4.682 | 4.682 | |
| Garrett Winslow General Counsel - [O] | 1.854 | 1.854 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i DMRA / Damora Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i DMRA / Damora Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | 2026-03-30 | 4 | Jarrett Jennifer | DMRA | Common Stock | D | 500.000 | 500.000 | ||||||
| 2026-02-12 | 2026-02-09 | 4 | Bruno Julianne | GLTO | Common Stock | D | 129.000 | 137.032 | ||||||
| 2026-02-12 | 2026-02-09 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Co-Invest V L.P. | GLTO | Common Stock | I | 2.904.000 | 2.904.000 | ||||||
| 2026-02-12 | 2026-02-09 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. | GLTO | Common Stock | I | 5.809.000 | 5.809.000 | ||||||
| 2026-01-26 | 2026-01-05 | 4 | Sattarzadeh Sherwin | GLTO | Common Stock | D | 190.376 | 190.376 | ||||||
| 2026-01-07 | 2026-01-05 | 4 | Hewes L. Becker | GLTO | Common Stock | D | 264.629 | 264.629 | ||||||
| 2026-01-06 | 2026-01-02 | 4 | Firmani Lori | GLTO | Common Stock | D | 21,4100 | -135 | -3 | 931 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Firmani Lori | GLTO | Common Stock | D | 374 | 1.066 | ||||||
| 2026-01-06 | 2026-01-02 | 4 | Winslow Garrett | GLTO | Common Stock | D | 21,3800 | -255 | -5 | 1.854 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Winslow Garrett | GLTO | Common Stock | D | 680 | 2.109 | ||||||
| 2026-01-06 | 2026-01-02 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 21,3800 | -700 | -15 | 4.682 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 1.360 | 5.382 | ||||||
| 2025-11-17 | 3 | Bruno Julianne | GLTO | Common Stock | D | 8.032 | ||||||||
| 2025-07-08 | 2025-07-03 | 4 | Firmani Lori | GLTO | Common Stock | D | 3,3900 | -147 | -0 | 692 | ||||
| 2025-07-08 | 2025-07-03 | 4 | Firmani Lori | GLTO | Common Stock | D | 374 | 839 | ||||||
| 2025-07-08 | 2025-07-03 | 4 | Winslow Garrett | GLTO | Common Stock | D | 3,3900 | -260 | -1 | 1.429 | ||||
| 2025-07-08 | 2025-07-03 | 4 | Winslow Garrett | GLTO | Common Stock | D | 680 | 1.689 | ||||||
| 2025-07-08 | 2025-07-03 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 3,3800 | -735 | -2 | 4.022 | ||||
| 2025-07-08 | 2025-07-03 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 1.360 | 4.757 | ||||||
| 2025-01-07 | 2025-01-03 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 5,6000 | -1.341 | -8 | 3.397 | ||||
| 2025-01-07 | 2025-01-03 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 2.640 | 4.738 | ||||||
| 2025-01-07 | 2025-01-03 | 4 | Firmani Lori | GLTO | Common Stock | D | 5,6300 | -261 | -1 | 465 | ||||
| 2025-01-07 | 2025-01-03 | 4 | Firmani Lori | GLTO | Common Stock | D | 726 | 726 | ||||||
| 2025-01-07 | 2025-01-03 | 4 | Winslow Garrett | GLTO | Common Stock | D | 5,6000 | -471 | -3 | 1.009 | ||||
| 2025-01-07 | 2025-01-03 | 4 | Winslow Garrett | GLTO | Common Stock | D | 1.320 | 1.480 | ||||||
| 2023-08-17 | 2023-08-15 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 0,7500 | -535.534 | -402 | 1.510.375 | ||||
| 2023-08-17 | 2023-08-15 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 0,7500 | -248.819 | -187 | 631.048 | ||||
| 2023-08-17 | 2023-08-15 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 0,7500 | -38.327 | -29 | 97.204 | ||||
| 2023-08-02 | 2023-07-31 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 3,0000 | -153.078 | -459 | 2.105.909 | ||||
| 2023-08-02 | 2023-07-31 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 3,0000 | -29.700 | -89 | 879.867 | ||||
| 2023-08-02 | 2023-07-31 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 3,0000 | -26.622 | -80 | 135.531 | ||||
| 2023-07-27 | 2023-07-25 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,9200 | -26.700 | -78 | 2.258.987 | ||||
| 2023-07-27 | 2023-07-25 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,9200 | -4.700 | -14 | 909.567 | ||||
| 2023-07-27 | 2023-07-25 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,9200 | -7.800 | -23 | 162.153 | ||||
| 2023-07-17 | 2023-07-13 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,4000 | -132.100 | -317 | 2.285.687 | ||||
| 2023-07-17 | 2023-07-13 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,4000 | -52.800 | -127 | 914.267 | ||||
| 2023-07-17 | 2023-07-13 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,4000 | -9.800 | -24 | 169.953 | ||||
| 2023-04-17 | 2023-04-17 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,9700 | -8.878 | -17 | 2.417.787 | ||||
| 2023-04-17 | 2023-04-17 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,9700 | -3.551 | -7 | 967.067 | ||||
| 2023-04-17 | 2023-04-17 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,9700 | -660 | -1 | 179.753 | ||||
| 2023-04-17 | 2023-04-14 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8600 | -28.110 | -52 | 2.426.665 | ||||
| 2023-04-17 | 2023-04-14 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8600 | -11.245 | -21 | 970.618 | ||||
| 2023-04-17 | 2023-04-14 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8600 | -2.091 | -4 | 180.413 | ||||
| 2023-04-17 | 2023-04-13 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8200 | -9.459 | -17 | 2.454.775 | ||||
| 2023-04-17 | 2023-04-13 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8200 | -3.784 | -7 | 981.863 | ||||
| 2023-04-17 | 2023-04-13 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8200 | -703 | -1 | 182.504 | ||||
| 2023-04-12 | 2023-04-12 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8100 | -1.603 | -3 | 2.464.234 | ||||
| 2023-04-12 | 2023-04-12 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8100 | -641 | -1 | 985.647 | ||||
| 2023-04-12 | 2023-04-12 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8100 | -119 | -0 | 183.207 | ||||
| 2023-04-12 | 2023-04-11 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8200 | -9.459 | -17 | 2.465.837 | ||||
| 2023-04-12 | 2023-04-11 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8200 | -3.784 | -7 | 986.288 | ||||
| 2023-04-12 | 2023-04-11 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,8200 | -703 | -1 | 183.326 | ||||
| 2023-04-12 | 2023-04-10 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,7900 | -34.745 | -62 | 2.500.582 | ||||
| 2023-04-12 | 2023-04-10 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,7900 | -13.899 | -25 | 1.000.187 | ||||
| 2023-04-12 | 2023-04-10 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 1,7900 | -2.584 | -5 | 185.910 | ||||
| 2023-04-07 | 2023-04-06 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,0000 | -6.558 | -13 | 2.510.041 | ||||
| 2023-04-07 | 2023-04-06 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,0000 | -2.620 | -5 | 1.003.971 | ||||
| 2023-04-07 | 2023-04-06 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,0000 | -487 | -1 | 186.613 | ||||
| 2023-04-07 | 2023-04-05 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,1800 | -63.058 | -137 | 2.516.599 | ||||
| 2023-04-07 | 2023-04-05 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,1800 | -25.220 | -55 | 1.006.591 | ||||
| 2023-04-07 | 2023-04-05 | 4 | ORBIMED ADVISORS LLC See footnotes | GLTO | Common Stock | I | 2,1800 | -4.687 | -10 | 187.100 | ||||
| 2022-03-23 | 2022-03-22 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 2,1500 | 5.000 | 11 | 52.428 | ||||
| 2022-03-23 | 2022-03-22 | 4 | Lindmark Bertil | GLTO | Common Stock | D | 2,1600 | 14.604 | 32 | 16.604 | ||||
| 2022-02-15 | 2022-02-15 | 4 | Oestreich Stephanie | GLTO | Stock Option (right to buy) | D | 2,07 | 140.000 | 140.000 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Schambye Hans T. | GLTO | Stock Option (right to buy) | D | 3,24 | 287.500 | 287.500 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Freve Jonathan | GLTO | Stock Option (right to buy) | D | 3,24 | 118.750 | 118.750 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Pedersen Anders | GLTO | Stock Option (right to buy) | D | 3,24 | 118.750 | 118.750 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Winslow Garrett | GLTO | Stock Option (right to buy) | D | 3,24 | 75.000 | 75.000 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Lindmark Bertil | GLTO | Stock Option (right to buy) | D | 3,24 | 118.750 | 118.750 | |||||
| 2021-12-06 | 2021-12-03 | 4 | Freve Jonathan | GLTO | Common Stock | D | 2,4900 | 4.000 | 10 | 12.000 | ||||
| 2021-12-06 | 2021-12-03 | 4 | Winslow Garrett | GLTO | Common Stock | D | 2,4800 | 2.000 | 5 | 4.000 | ||||
| 2021-11-19 | 2021-11-17 | 4 | GOLDFISCHER CARL | GLTO | Stock Option (right to buy) | D | 3,23 | 18.000 | 18.000 | |||||
| 2021-11-19 | 2021-11-17 | 4 | Khuong Chau Quang | GLTO | Stock Option (right to buy) | D | 3,23 | 9.000 | 9.000 | |||||
| 2021-11-10 | 2021-11-09 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 3,5000 | 4.500 | 16 | 47.428 | ||||
| 2021-11-09 | 2021-11-08 | 4 | Freve Jonathan | GLTO | Common Stock | D | 3,4000 | 3.000 | 10 | 8.000 | ||||
| 2021-08-19 | 2021-08-18 | 4 | Freve Jonathan | GLTO | Common Stock | D | 3,9200 | 3.000 | 12 | 5.000 | ||||
| 2021-06-28 | 2021-06-28 | 4 | Lindmark Bertil | GLTO | Common Stock | D | 5,2600 | 2.000 | 11 | 2.000 | ||||
| 2021-06-24 | 2021-06-24 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 5,1100 | 3.000 | 15 | 42.928 | ||||
| 2021-06-23 | 2021-06-23 | 4 | Freve Jonathan | GLTO | Common Stock | D | 4,7400 | 2.000 | 9 | 2.000 | ||||
| 2021-06-23 | 2021-06-23 | 4 | Winslow Garrett | GLTO | Common Stock | D | 4,8000 | 2.000 | 10 | 2.000 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Winslow Garrett | GLTO | Stock Option (right to buy) | D | 5,61 | 120.000 | 120.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Prener Anne | GLTO | Stock Option (right to buy) | D | 4,93 | 18.000 | 18.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | GOLDFISCHER CARL | GLTO | Stock Option (right to buy) | D | 4,93 | 18.000 | 18.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Khuong Chau Quang | GLTO | Stock Option (right to buy) | D | 4,93 | 18.000 | 18.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Dallas Jayson Donald Alexander | GLTO | Stock Option (right to buy) | D | 4,93 | 18.000 | 18.000 | |||||
| 2021-01-08 | 2021-01-08 | 4 | Prener Anne | GLTO | Stock Option (right to buy) | D | 13,12 | 6.000 | 6.000 | |||||
| 2021-01-08 | 2021-01-08 | 4 | Prener Anne | GLTO | Stock Option (right to buy) | D | 13,12 | 18.000 | 18.000 | |||||
| 2021-01-07 | 2021-01-05 | 4 | Lindmark Bertil | GLTO | Stock Option (right to buy) | D | 13,00 | 95.000 | 95.000 | |||||
| 2021-01-07 | 2021-01-05 | 4 | Freve Jonathan | GLTO | Stock Option (right to buy) | D | 13,00 | 95.000 | 95.000 | |||||
| 2021-01-07 | 2021-01-05 | 4 | Pedersen Anders | GLTO | Stock Option (right to buy) | D | 13,00 | 100.000 | 100.000 | |||||
| 2021-01-07 | 2021-01-05 | 4 | Schambye Hans T. | GLTO | Stock Option (right to buy) | D | 13,00 | 230.000 | 230.000 | |||||
| 2020-11-23 | 2020-11-19 | 4 | Dallas Jayson Donald Alexander | GLTO | Stock Option (right to buy) | D | 16,60 | 9.000 | 9.000 | |||||
| 2020-11-23 | 2020-11-19 | 4 | Dallas Jayson Donald Alexander | GLTO | Stock Option (right to buy) | D | 16,60 | 18.000 | 18.000 | |||||
| 2020-11-04 | 2020-11-02 | 4 | Christgau Stephan | GLTO | Series D Preferred Stock | I | -184.433 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Christgau Stephan | GLTO | Common Stock | I | 15,0000 | 66.666 | 1.000 | 546.136 | ||||
| 2020-11-04 | 2020-11-02 | 4 | Christgau Stephan | GLTO | Common Stock | I | 479.470 | 479.470 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series D Preferred Stock | I | -73.773 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series D Preferred Stock | I | -59.350 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series D Preferred Stock | I | -148.395 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series C-5 Preferred Stock | I | -31.147 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series C-5 Preferred Stock | I | -77.866 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series C-4 Preferred Stock | I | -109.013 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series C-4 Preferred Stock | I | -272.533 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series C-2 Preferred Stock | I | -116.800 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Series C-2 Preferred Stock | I | -291.999 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Common Shares | I | 15,0000 | 209.500 | 3.142 | 1.031.811 | ||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Common Shares | I | 15,0000 | 523.833 | 7.857 | 2.579.657 | ||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Common Shares | I | 191.787 | 191.787 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Common Shares | I | 822.311 | 822.311 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Khuong Chau Quang | GLTO | Common Shares | I | 2.055.824 | 2.055.824 | ||||||
| 2020-11-04 | 2020-09-25 | 4 | Khuong Chau Quang | GLTO | Series D Preferred Stock | I | 27,1100 | -73.773 | -2.000 | 73.773 | ||||
| 2020-11-04 | 2020-09-25 | 4 | Khuong Chau Quang | GLTO | Series D Preferred Stock | I | 27,1100 | -59.350 | -1.609 | 59.350 | ||||
| 2020-11-04 | 2020-09-25 | 4 | Khuong Chau Quang | GLTO | Series D Preferred Stock | I | 27,1100 | -148.395 | -4.023 | 148.395 | ||||
| 2020-11-04 | 2020-11-02 | 4 | Schambye Hans T. | GLTO | Series C-1 Preferred Stock | D | -5.359 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Schambye Hans T. | GLTO | Common Stock | D | 13.931 | 39.928 | ||||||
| 2020-11-04 | 2020-10-07 | 4 | Schambye Hans T. | GLTO | Stock Option (right to buy) | D | 7,70 | 519.940 | 519.940 | |||||
| 2020-11-04 | 2020-06-24 | 4 | Schambye Hans T. | GLTO | Stock Option (right to buy) | D | 1,95 | 207.976 | 207.976 | |||||
| 2020-11-04 | 2020-11-02 | 4 | Munshi Amit | GLTO | Series D Preferred Stock | D | -1.844 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Munshi Amit | GLTO | Common Stock | D | 4.793 | 4.793 | ||||||
| 2020-11-04 | 2020-09-25 | 4 | Munshi Amit | GLTO | Series D Preferred Stock | D | 27,1100 | 1.844 | 50 | 1.844 | ||||
| 2020-11-04 | 2020-06-24 | 4 | Munshi Amit | GLTO | Stock Option (right to buy) | D | 1,95 | 109.187 | 109.187 | |||||
| 2020-11-04 | 2020-11-02 | 4 | Pedersen Anders | GLTO | Series C-1 Preferred Stock | D | -1.441 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Pedersen Anders | GLTO | Common Stock | D | 3.746 | 3.746 | ||||||
| 2020-11-04 | 2020-10-07 | 4 | Pedersen Anders | GLTO | Stock Option (right to buy) | D | 7,70 | 77.991 | 77.991 | |||||
| 2020-11-04 | 2020-06-24 | 4 | Pedersen Anders | GLTO | Stock Option (right to buy) | D | 1,95 | 142.983 | 142.983 | |||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series D Preferred Stock | I | -73.773 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series D Preferred Stock | I | -59.350 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series D Preferred Stock | I | -148.395 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series C-5 Preferred Stock | I | -31.147 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series C-5 Preferred Stock | I | -77.866 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series C-4 Preferred Stock | I | -109.013 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series C-4 Preferred Stock | I | -272.533 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series C-2 Preferred Stock | I | -116.800 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Series C-2 Preferred Stock | I | -291.999 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Common Shares | I | 15,0000 | 209.500 | 3.142 | 1.031.811 | ||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Common Shares | I | 15,0000 | 523.833 | 7.857 | 2.579.657 | ||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Common Shares | I | 191.787 | 191.787 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Common Shares | I | 822.311 | 822.311 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | ORBIMED ADVISORS LLC | GLTO | Common Shares | I | 2.055.824 | 2.055.824 | ||||||
| 2020-11-04 | 2020-09-25 | 4 | ORBIMED ADVISORS LLC | GLTO | Series D Preferred Stock | I | 27,1100 | -73.773 | -2.000 | 73.773 | ||||
| 2020-11-04 | 2020-09-25 | 4 | ORBIMED ADVISORS LLC | GLTO | Series D Preferred Stock | I | 27,1100 | -59.350 | -1.609 | 59.350 | ||||
| 2020-11-04 | 2020-09-25 | 4 | ORBIMED ADVISORS LLC | GLTO | Series D Preferred Stock | I | 27,1100 | -148.395 | -4.023 | 148.395 | ||||
| 2020-11-04 | 2020-11-02 | 4 | GOLDFISCHER CARL | GLTO | Series D Preferred Stock | D | -3.688 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | GOLDFISCHER CARL | GLTO | Series C-3 Preferred Stock | I | -7.475 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | GOLDFISCHER CARL | GLTO | Series C-3 Preferred Stock | I | -392.367 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | GOLDFISCHER CARL | GLTO | Common Stock | I | 19.432 | 19.432 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | GOLDFISCHER CARL | GLTO | Common Stock | I | 1.020.036 | 1.020.036 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | GOLDFISCHER CARL | GLTO | Common Stock | D | 9.587 | 9.587 | ||||||
| 2020-11-04 | 2020-09-25 | 4 | GOLDFISCHER CARL | GLTO | Series D Preferred Stock | D | 27,1100 | 3.688 | 100 | 3.688 | ||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES D PREFERRED STOCK | D | -98.930 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES C-5 PREFERRED STOCK | D | -51.911 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES C-4 PREFERRED STOCK | D | -181.688 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES C-2 PREFERRED STOCK | D | -194.666 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES C-1 PREFERRED STOCK | D | -133.991 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES B-4 PREFERRED STOCK | D | -66.666 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES B-3 PREFERRED STOCK | D | -63.333 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES B-2 PREFERRED STOCK | D | -15.833 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | SERIES B-1 PREFERRED STOCK | D | -25.562 | 0 | ||||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | COMMON STOCK | D | 15,0000 | 333.333 | 5.000 | 2.497.791 | ||||
| 2020-11-04 | 2020-11-02 | 4 | Novo A/S | GLTO | COMMON STOCK | D | 2.164.458 | 2.164.458 | ||||||
| 2020-10-28 | 3 | Schambye Hans T. | GLTO | Common Stock | D | 25.997 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
